apceth Biopharma GmbH is a fully owned subsidiary of Hitachi Chemical Co., Ltd. The Hitachi Chemical Regenerative Medicine Business Sector includes operations in North America, Europe, and Japan. The business leverages two decades of experience exclusively focused on the cell therapy industry and its global footprint totals over 200,000 square feet.
It provides contract development and manufacturing services designed to meet region-specific regulation based on Good Manufacturing Practices standards. Clients enjoy ideal geographic coverage, access to major cell and gene therapy markets, and region-specific regulatory expertise.